Intra-ovarian injection of autologous menstrual blood-derived-mesenchymal stromal cells: a safe and promising method to improve pregnancy rate in poor ovarian responders
Abstract Background Poor ovarian response (POR) significantly reduces the success rates of fertility treatments. This study investigates the long-term efficacy and potential complications associated with autologous menstrual blood-derived mesenchymal stromal cells (MenSCs) therapy in improving ferti...
Saved in:
| Main Authors: | Simin Zafardoust, Hamidreza Didar, Maryam Ghasemi Ganagard, Maryam Tavakoli, Soheila Arefi, Shaghayegh Arjmandinaloo, Mina Fathi-Kazerooni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Stem Cell Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13287-025-04278-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meta-analysis highlight the therapeutic potential of stem cells for premature ovarian failure
by: Amna Umer, et al.
Published: (2024-06-01) -
Amelioration of female menopausal syndrome by intravenous administration of autologous menstrual blood-derived stem cells
by: Hiromi Izawa, et al.
Published: (2025-06-01) -
PEDF-Expressing mesenchymal stem cells restore ovarian function via Tim-3-Mediated immune modulation in primary ovarian failure
by: Seyida Yimamuyushan, et al.
Published: (2025-08-01) -
Advances in in vitro oocyte generation from pluripotent stem cells and ovarian stem cells
by: Mingxin Tian, et al.
Published: (2025-08-01) -
Sustained release of miR-21 carried by mesenchymal stem cell-derived exosomes from GelMA microspheres inhibits ovarian granulosa cell apoptosis in premature ovarian insufficiency
by: Xiaofei Zhang, et al.
Published: (2025-04-01)